- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.4: 6 residues within 4Å:- Chain A: G.77, K.78, R.81, Q.117, R.134
- Ligands: PO4.5
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:K.78
- Water bridges: A:G.77, A:Y.79, A:N.80, A:R.81, A:R.81, A:E.114
- Salt bridges: A:R.81, A:R.134
PO4.5: 8 residues within 4Å:- Chain A: R.81, Q.117, R.133, F.260, D.264, K.278
- Ligands: PO4.4, RIS.6
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:Q.117, A:Q.117, A:D.264
- Salt bridges: A:R.81, A:R.133, A:K.278
PO4.10: 6 residues within 4Å:- Chain B: G.77, K.78, R.81, Q.117, R.134
- Ligands: PO4.11
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:K.78
- Water bridges: B:G.77, B:Y.79, B:N.80, B:R.81, B:R.81, B:E.114
- Salt bridges: B:R.81, B:R.134
PO4.11: 8 residues within 4Å:- Chain B: R.81, Q.117, R.133, F.260, D.264, K.278
- Ligands: PO4.10, RIS.12
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:Q.117, B:Q.117
- Salt bridges: B:R.81, B:R.133, B:K.278
- 2 x RIS: 1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE BIS-PHOSPHONIC ACID(Non-covalent)
RIS.6: 15 residues within 4Å:- Chain A: L.121, D.124, D.128, R.133, Q.192, K.221, T.222, Y.225, Q.261, D.264, K.278
- Ligands: MG.1, MG.2, MG.3, PO4.5
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:L.121
- Hydrogen bonds: A:D.128, A:R.133, A:R.133, A:Y.225, A:Q.261, A:Q.261, A:D.264, A:K.278, A:K.278, A:K.278
- Water bridges: A:S.130, A:K.221, A:K.221, A:D.268
RIS.12: 15 residues within 4Å:- Chain B: L.121, D.124, D.128, R.133, Q.192, K.221, T.222, Y.225, Q.261, D.264, K.278
- Ligands: MG.7, MG.8, MG.9, PO4.11
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:L.121
- Hydrogen bonds: B:R.133, B:R.133, B:Q.261, B:Q.261, B:D.264, B:K.278, B:K.278, B:K.278
- Water bridges: B:S.130, B:K.221, B:K.221, B:D.264, B:D.264
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kavanagh, K.L. et al., Human farnesyl diphosphate complexed with clinical inhibitor risedronate. To be Published
- Release Date
- 2005-02-22
- Peptides
- Farnesyl pyrophosphate synthetase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- 2 x RIS: 1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE BIS-PHOSPHONIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kavanagh, K.L. et al., Human farnesyl diphosphate complexed with clinical inhibitor risedronate. To be Published
- Release Date
- 2005-02-22
- Peptides
- Farnesyl pyrophosphate synthetase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A